{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T21:17:26Z","timestamp":1776374246355,"version":"3.51.2"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T00:00:00Z","timestamp":1546473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Womens Ment Health"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00737-018-0933-z","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T07:44:05Z","timestamp":1546501445000},"page":"711-721","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Managing fibromyalgia syndrome in pregnancy no bridges between USA and EU"],"prefix":"10.1007","volume":"22","author":[{"given":"Salvatore","family":"Gentile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luigia","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,3]]},"reference":[{"key":"933_CR1","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1177\/0009922812450509","volume":"52","author":"NA Abdy","year":"2013","unstructured":"Abdy NA, Gerhart K (2013) Duloxetine withdrawal syndrome in a newborn. Clin Pediatr (Phila) 52:976\u2013977","journal-title":"Clin Pediatr (Phila)"},{"key":"933_CR2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Arlington, VA, American Psychiatric Association","edition":"4"},{"key":"933_CR3","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1080\/14767058.2016.1243096","volume":"30","author":"M Atasever","year":"2017","unstructured":"Atasever M, Naml\u0131 Kalem M, S\u00f6nmez \u00c7 et al (2017) Lower serotonin level and higher rate of fibromyalgia syndrome with advancing pregnancy. J Matern Fetal Neonatal Med 30:2204\u20132211","journal-title":"J Matern Fetal Neonatal Med"},{"key":"933_CR4","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s40261-013-0112-y","volume":"33","author":"C Bellantuono","year":"2013","unstructured":"Bellantuono C, Marini A, Lucarelli C (2013) Infant health and neurodevelopmental outcomes following prenatal exposure to duloxetine. Clin Drug Investig 33:685\u2013688","journal-title":"Clin Drug Investig"},{"key":"933_CR5","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/bcp.13194","volume":"83","author":"A B\u00e9rard","year":"2017","unstructured":"B\u00e9rard A, Sheehy O, Zhao JP et al (2017) SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn. Br J Clin Pharmacol 83:1126\u20131133","journal-title":"Br J Clin Pharmacol"},{"key":"933_CR6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/ejp.1121","volume":"22","author":"K Bernardy","year":"2018","unstructured":"Bernardy K, Klose P, Welsch P et al (2018) Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome. A systematic review and meta-analysis of randomized controlled trials. Eur J Pain 22:242\u2013260","journal-title":"Eur J Pain"},{"key":"933_CR7","first-page":"CD011755","volume":"9","author":"J Bidonde","year":"2017","unstructured":"Bidonde J, Busch AJ, van der Spuy I et al (2017) Whole body vibration exercise training for fibromyalgia. Cochrane Database Syst Rev 9:CD011755","journal-title":"Cochrane Database Syst Rev"},{"key":"933_CR8","unstructured":"Bollettino di informazione sui farmaci. (2017) http:\/\/www.agenziafarmaco.gov.it\/wscs_render_attachment_by_id\/111.285018.115401469992960af.pdf?id=111.285023.1154014700132 . Accessed: September, 15, 2017"},{"key":"933_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00737-011-0215-5","volume":"14","author":"PM Boyce","year":"2011","unstructured":"Boyce PM, Hackett LP, Ilett KF (2011) Duloxetine transfer across the placenta during pregnancy and into milk during lactation. Arch Womens Ment Health 14:169\u2013172","journal-title":"Arch Womens Ment Health"},{"key":"933_CR10","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1345\/aph.1M317","volume":"43","author":"GG Briggs","year":"2009","unstructured":"Briggs GG, Ambrose PJ, Ilett KF et al (2009) Use of duloxetine in pregnancy and lactation. Ann Pharmacother 43:1898\u20131902","journal-title":"Ann Pharmacother"},{"key":"933_CR11","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1001\/jama.2017.3415","volume":"317","author":"HK Brown","year":"2017","unstructured":"Brown HK, Ray JG, Wilton AS, Lunsky Y, Gomes T, Vigod SN (2017) Association between serotonergic antidepressant use during pregnancy and autism spectrum disorder in children. JAMA 317:1544\u20131552","journal-title":"JAMA"},{"key":"933_CR12","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00737-016-0655-z","volume":"19","author":"MGP Ocampo De","year":"2016","unstructured":"De Ocampo MGP, Araneta MRG, Macera CA et al (2016) Risk of gestational hypertension and preeclampsia in women who discontinued or continued antidepressant medication use during pregnancy. Arch Womens Ment Health 19:1051\u20131061","journal-title":"Arch Womens Ment Health"},{"key":"933_CR13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1748-720X.2009.00408.x","volume":"37","author":"R Dresser","year":"2009","unstructured":"Dresser R, Frader J (2009) Off-label prescribing: a call for heightened professional and government oversight. J Law Med Ethics 37:476\u2013486","journal-title":"J Law Med Ethics"},{"key":"933_CR14","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.4088\/JCP.12l08013","volume":"73","author":"A Einarson","year":"2012","unstructured":"Einarson A, Smart K, Vial T, Diav-Citrin O, Yates L, Stephens S, Pistelli A, Kennedy D, Taylor T, Panchaud A, Malm H, Koren G, Einarson TR (2012) Rates of major malformations in infants following exposure to duloxetine during pregnancy: a preliminary report. J Clin Psychiatry 73:1471","journal-title":"J Clin Psychiatry"},{"key":"933_CR15","unstructured":"EMEA. Refusal assessment report for Cymbalta (2008). http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Assessment_Report_-_Variation\/human\/000572\/WC500076168.pdf . Accessed: February 16, 2018"},{"key":"933_CR16","unstructured":"EMEA. (2009) Milnacipran Pierre Fabre Medicament. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/001034\/human_med_001311.jsp&murl=menus\/medicines\/medicines.jsp&mid=WC0b01ac058001d125 . Accessed: February 16, 2018"},{"key":"933_CR17","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1176\/appi.ajp.2008.07071194","volume":"65","author":"R Eyal","year":"2008","unstructured":"Eyal R, Yaeger D (2008) Poor neonatal adaptation after in utero exposure to duloxetine. Am J Psychiatry 65:651","journal-title":"Am J Psychiatry"},{"key":"933_CR18","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/journalofethics.2016.18.6.ecas3-1606","volume":"18","author":"K Furey","year":"2016","unstructured":"Furey K, Wilkins K (2016) Prescribing \u201coff-label\u201d: what should a physician disclose? AMA J Ethics 18:587\u2013593","journal-title":"AMA J Ethics"},{"key":"933_CR19","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1517\/17425255.2015.1063614","volume":"11","author":"S Gentile","year":"2015","unstructured":"Gentile S (2015) Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms. Expert Opin Drug Metab Toxicol 11:1585\u20131597","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"933_CR20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-3-642-54562-7_7","volume-title":"Anxiety and sleep disorders, psychopharmacology and pregnancy. In: psychopharmacology and pregnancy. Galbally, Snellen, and Lewis Edts","author":"S Gentile","year":"2014","unstructured":"Gentile S (2014) Anxiety and sleep disorders, psychopharmacology and pregnancy. In: psychopharmacology and pregnancy. Galbally, Snellen, and Lewis Edts. Springer Verlab, Berlin, pp 87\u2013102"},{"key":"933_CR21","doi-asserted-by":"publisher","first-page":"e7367","DOI":"10.1136\/bmj.e7367","volume":"345","author":"S Gentile","year":"2012","unstructured":"Gentile S (2012) Bipolar disorder in pregnancy: to treat or not to treat? The real question is how to treat most effectively. Br Med J 345:e7367. https:\/\/doi.org\/10.1136\/bmj.e7367","journal-title":"Br Med J"},{"key":"933_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1017\/S1092852900027449","volume":"15","author":"S Gentile","year":"2010","unstructured":"Gentile S (2010) On categorizing gestational birth, and neonatal complications following late in utero exposure to antidepressants. The prenatal antidepressant exposure syndrome. CNS Spectr 15:167\u2013185","journal-title":"CNS Spectr"},{"key":"933_CR23","unstructured":"Guzman F. (2018) Pharmacology corner. Pregabalin (Lyrica) not approved for fibromyalgia by the EMEA. http:\/\/pharmacologycorner.com\/pregabalin-lyrica-not-approved-fibromyalgia-emea\/ . Accessed: February 16, 201"},{"key":"933_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1192\/bjp.bp.116.181396","volume":"209","author":"E Hedman","year":"2016","unstructured":"Hedman E, Axelsson E, Andersson E, Lekander M, Lj\u00f3tsson B (2016) Exposure-based cognitive-behavioural therapy via the internet and as bibliotherapy for somatic symptom disorder and illness anxiety disorder: randomised controlled trial. Br J Psychiatry 209:407\u2013413","journal-title":"Br J Psychiatry"},{"key":"933_CR25","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1080\/10503307.2016.1265686","volume":"28","author":"J Heider","year":"2017","unstructured":"Heider J, K\u00f6ck K, Sehlbrede M, Schr\u00f6der A (2017) Readiness to change as a moderator of therapy outcome in patients with somatoform disorders. Psychother Res 28:722\u2013733. https:\/\/doi.org\/10.1080\/10503307.2016.1265686","journal-title":"Psychother Res"},{"key":"933_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000484413","volume":"87","author":"P Henningsen","year":"2018","unstructured":"Henningsen P, Zipfel S, Sattel H et al (2018) Management of functional somatic syndromes and bodily distress. Psychother Psychosom 87:12\u201331","journal-title":"Psychother Psychosom"},{"key":"933_CR27","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ejpn.2016.11.003","volume":"21","author":"J Holland","year":"2017","unstructured":"Holland J, Brown R (2017) Neonatal venlafaxine discontinuation syndrome: a mini-review. Eur J Paediatr Neurol 21:264\u2013268","journal-title":"Eur J Paediatr Neurol"},{"key":"933_CR28","doi-asserted-by":"publisher","first-page":"413","DOI":"10.7150\/ijms.5213","volume":"10","author":"SL Hoog","year":"2013","unstructured":"Hoog SL, Cheng Y, Elpers J, Dowsett SA (2013) Duloxetine and pregnancy outcomes: safety surveillance findings. Int J Med Sci 10:413\u2013419","journal-title":"Int J Med Sci"},{"key":"933_CR29","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/hup.696","volume":"20","author":"JI Hudson","year":"2005","unstructured":"Hudson JI, Wohlreich MM, Daniel K, Kajdasz DK (2005) Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials. Hum Psychopharmacol Clin Exp 20:327\u2013341","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"933_CR30","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3390\/ph6101221","volume":"6","author":"B K\u00e4ll\u00e9n","year":"2013","unstructured":"K\u00e4ll\u00e9n B, Borg N, Reis M (2013) The use of central nervous system active drugs during pregnancy. Pharmaceuticals 6:1221\u20131286","journal-title":"Pharmaceuticals"},{"key":"933_CR31","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.brs.2017.06.006","volume":"10","author":"EM Khedr","year":"2017","unstructured":"Khedr EM, Omran EAH, Ismail NM, el-Hammady DH, Goma SH, Kotb H, Galal H, Osman AM, Farghaly HSM, Karim AA, Ahmed GA (2017) Effects of transcranial direct current stimulation on pain, mood and serum endorphin level in the treatment of fibromyalgia: a double blinded, randomized clinical trial. Brain Stimul 10:893\u2013901","journal-title":"Brain Stimul"},{"key":"933_CR32","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cpr.2010.09.001","volume":"31","author":"M Kleinst\u00e4uber","year":"2011","unstructured":"Kleinst\u00e4uber M, Witth\u00f6ft M, Hiller W (2011) Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: a meta-analysis. Clin Psychol Rev 31:146\u2013160","journal-title":"Clin Psychol Rev"},{"key":"933_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2165\/11539240-000000000-00000","volume":"50","author":"MP Knadler","year":"2011","unstructured":"Knadler MP, Lobo E, Chappell J, Bergstrom R (2011) Duloxetine: clinical pharmacokinetics and drug interactions. Clin Pharmacokinet 50:281\u2013294","journal-title":"Clin Pharmacokinet"},{"key":"933_CR34","doi-asserted-by":"publisher","first-page":"e72095","DOI":"10.1371\/journal.pone.0072095","volume":"8","author":"MI Kjaersgaard","year":"2013","unstructured":"Kjaersgaard MI, Parner ET, Vestergaard M et al (2013) Prenatal antidepressant exposure and risk of spontaneous abortion: a population-based study. PLoS One 8:e72095","journal-title":"PLoS One"},{"key":"933_CR35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.psc.2007.08.002","volume":"30","author":"K Kroenke","year":"2000","unstructured":"Kroenke K (2000) Somatoform disorders and recent diagnostic controversies. Psychiatr Clin North Am 30:593\u2013619","journal-title":"Psychiatr Clin North Am"},{"key":"933_CR36","first-page":"637","volume":"7","author":"RJ Leo","year":"2006","unstructured":"Leo RJ, Brooks VL (2006) Clinical potential of milnacipran, a serotonin and norepinephrine reuptake inhibitor, in pain. Curr Opin Investig Drugs 7:637\u2013642","journal-title":"Curr Opin Investig Drugs"},{"key":"933_CR37","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1124\/dmd.112.045120","volume":"40","author":"F Li","year":"2012","unstructured":"Li F, Chin C, Wangsa J, Ho J (2012) Excretion and metabolism of milnacipran in humans after oral administration of milnacipran hydrochloride. Drug Metab Dispos 40:1723\u20131735","journal-title":"Drug Metab Dispos"},{"key":"933_CR38","doi-asserted-by":"publisher","first-page":"W-65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","volume":"151","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151:W-65","journal-title":"Ann Intern Med"},{"key":"933_CR39","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1002\/pds.4286","volume":"26","author":"A Lupattelli","year":"2017","unstructured":"Lupattelli A, Wood M, Lapane K, Spigset O, Nordeng H (2017) Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: a study from the Norwegian Mother and Child Cohort Study. Pharmacoepidemiol Drug Saf 26:1266\u20131276","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"933_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14767058.2017.1381684","volume":"27","author":"GG Magtanong","year":"2017","unstructured":"Magtanong GG, Spence AR, Czuzoj-Shulman N, Abenhaim HA (2017) Maternal and neonatal outcomes among pregnant women with fibromyalgia: a population-based study of 12 million births. J Matern Fetal Neonatal Med Sep 27:1\u20137. https:\/\/doi.org\/10.1080\/14767058.2017.1381684","journal-title":"J Matern Fetal Neonatal Med Sep"},{"key":"933_CR41","unstructured":"Medscape. News and perspectives. (2008) Cymbalta approved for fibromyalgia. https:\/\/www.medscape.org\/viewarticle\/576320. Accessed February 16 , 2018"},{"key":"933_CR42","unstructured":"Medscape. News and perspectives. (2009) FDA approves milnacipran for fibromyalgia https:\/\/www.medscape.com\/viewarticle\/586898 . Accessed: February 16"},{"key":"933_CR43","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1136\/jnnp-2017-316143","volume":"89","author":"B Mostacci","year":"2018","unstructured":"Mostacci B, Poluzzi E, D\u2019Alessandro R, On behalf of the ESPEA Study Group et al (2018) Adverse pregnancy outcomes in women exposed to gabapentin and pregabalin: data from a population-based study. J Neurol Neurosurg Psychiatry 89:223\u2013224","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"933_CR44","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.4088\/JCP.15m10506","volume":"77","author":"JD Newport","year":"2016","unstructured":"Newport JD, Hostetter AL, Juul SH et al (2016) Prenatal psychostimulant and antidepressant exposure and risk of hypertensive disorders in pregnancy. J Clin Psychiatry 77:1538\u20131545","journal-title":"J Clin Psychiatry"},{"key":"933_CR45","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1212\/WNL.0000000000003959","volume":"88","author":"E Patorno","year":"2017","unstructured":"Patorno E, Bateman BT, Huybrechts KF (2017) Pregabalin use early in pregnancy and the risk of major congenital malformations. Neurology 88:2020\u20132025","journal-title":"Neurology"},{"key":"933_CR46","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s00296-012-2627-6","volume":"33","author":"S Saa\u2019d","year":"2013","unstructured":"Saa\u2019d S, Many A, Jacob G et al (2013) High prevalence of fibromyalgia symptoms among healthy full-term pregnant women. Rheumatol Int 33:1555\u20131560","journal-title":"Rheumatol Int"},{"key":"933_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/MRR.0000000000000207","volume":"40","author":"M Saltychev","year":"2017","unstructured":"Saltychev M, Laimi K (2017) Effectiveness of repetitive transcranial magnetic stimulation in patients with fibromyalgia: a meta-analysis. Int J Rehabil Res 40:11\u201318","journal-title":"Int J Rehabil Res"},{"key":"933_CR48","unstructured":"Savella Pregnancy Registry (2009) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01026077 . Last update: September 22, 2016. Accessed: February 17, 2018"},{"key":"933_CR49","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/00005721-200407000-00010","volume":"29","author":"KM Schaefer","year":"2004","unstructured":"Schaefer KM (2004) Breastfeeding in chronic illness: the voices of women with fibromyalgia. MCN Am J Matern Child Nurs 29:248\u2013253","journal-title":"MCN Am J Matern Child Nurs"},{"key":"933_CR50","first-page":"296","volume":"37","author":"A Schr\u00f6der","year":"2013","unstructured":"Schr\u00f6der A, Heider J, Zaby A et al (2013) Cognitive behavioral therapy versus progressive muscle relaxation training for multiple somatoform disorders: results of a randomized controlled trial. CognitTher Res 37:296\u2013306","journal-title":"CognitTher Res"},{"issue":"9","key":"933_CR51","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1017\/S1092852900019726","volume":"10","author":"Stephen M. Stahl","year":"2005","unstructured":"Stahl SM, Grady MM, Moret C, et al (2005) SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr 10:732\u2013747","journal-title":"CNS Spectrums"},{"key":"933_CR52","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jama.2017.3413","volume":"317","author":"AC Sujan","year":"2017","unstructured":"Sujan AC, Rickert ME, \u00d6berg SA et al (2017) Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit\/hyperactivity disorder in offspring. JAMA 317:1553\u20131562","journal-title":"JAMA"},{"issue":"4","key":"933_CR53","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/jcpp.13004","volume":"60","author":"Ayesha C. Sujan","year":"2018","unstructured":"Sujan AC, \u00d6berg AS, Quinn PD, D'Onofrio BM (2018) Annual Research Review: Maternal antidepressant use during pregnancy and offspring neurodevelopmental problems - a critical review and recommendations for future research. J Child Psychol Psychiatry. https:\/\/doi.org\/10.1111\/jcpp.13004","journal-title":"Journal of Child Psychology and Psychiatry"},{"key":"933_CR54","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.clinthera.2007.01.013","volume":"29","author":"DM Tassone","year":"2007","unstructured":"Tassone DM, Boyce E, Guyer J, Nuzum D (2007) Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders. Clin Ther 29:26\u201348","journal-title":"Clin Ther"},{"key":"933_CR55","unstructured":"Temple University (2006) Fibromyalgia increases pain and fatigue for pregnant women. ScienceDaily. ScienceDaily, 5. www.sciencedaily.com\/releases\/2006\/07\/060705184726.htm . Accessed: September 20, 2017"},{"key":"933_CR56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/YIC.0b013e3282f41d7e","volume":"23","author":"MH Trivedi","year":"2008","unstructured":"Trivedi MH, Desaiah D, Ossanna MJ et al (2008) Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine. Int Clin Psychopharmacol 23:161\u2013169","journal-title":"Int Clin Psychopharmacol"},{"key":"933_CR57","doi-asserted-by":"publisher","first-page":"545","DOI":"10.12669\/pjms.323.9574","volume":"32","author":"KT Tulay","year":"2016","unstructured":"Tulay KT, Emrullah T, Aydin A et al (2016) The effect of fibromyalgia syndrome to gravidity, parity and duration of breastfeeding; a prospective study from Turkey. Pak J Med Sci 32:545\u2013549","journal-title":"Pak J Med Sci"},{"key":"933_CR58","first-page":"CD011142","volume":"11","author":"N Dessel van","year":"2014","unstructured":"van Dessel N, den Boeft M, van der Wouden JC et al (2014) On-pharmacological interventions for somatoform isorders and medically unexplained physical symptoms (MUPS) in adults. Cochr Database System Rev 11:CD011142","journal-title":"Cochr Database System Rev"},{"key":"933_CR59","doi-asserted-by":"publisher","first-page":"e0173397","DOI":"10.1371\/journal.pone.0173397","volume":"12","author":"LM Ravesteyn van","year":"2017","unstructured":"van Ravesteyn LM, Lambregtse-van den Berg MP, Hoogendijk WJP et al (2017) Interventions to treat mental disorders during pregnancy: a systematic review and multiple treatment meta-analysis. PLoS One 12:e0173397","journal-title":"PLoS One"},{"key":"933_CR60","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1113\/jphysiol.2008.152298","volume":"586","author":"N Weiss","year":"2008","unstructured":"Weiss N, Ivanova E (2008) Does the voltage-gated calcium channel alpha2delta-1 subunit play a dual function in skeletal muscle? J Physiol 586:2035\u20132037","journal-title":"J Physiol"},{"issue":"24","key":"933_CR61","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1212\/WNL.0000000000002767","volume":"86","author":"Ursula Winterfeld","year":"2016","unstructured":"Winterfeld U, Merlob P, Baud D, Rousson V, Panchaud A, Rothuizen LE, Bernard N, Vial T, Yates LM, Pistelli A, Ellfolk M, Eleftheriou G, de Vries LC, Jonville-Bera AP, Kadioglu M, Biollaz J, Buclin T (2016) Pregnancy outcome following maternal exposure to pregabalin may call for concern. Neurology 86(24):2251\u20132257. https:\/\/doi.org\/10.1212\/WNL.0000000000002767","journal-title":"Neurology"},{"key":"933_CR62","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3899\/jrheum.100594","volume":"38","author":"F Wolfe","year":"2011","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA et al (2011) Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 38:1113\u20131122","journal-title":"J Rheumatol"},{"key":"933_CR63","doi-asserted-by":"publisher","first-page":"e88740","DOI":"10.1371\/journal.pone.0088740","volume":"9","author":"F Wolfe","year":"2014","unstructured":"Wolfe F, Wallitt BT, Katz RS et al (2014) Symptoms, the nature of fibromyalgia, and Diagnostic and Statistical Manual 5 (DSM-5) defined mental illness in patients with rheumatoid arthritis and fibromyalgia. PLoS One 9:e88740","journal-title":"PLoS One"},{"key":"933_CR64","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3109\/14767058.2010.551152","volume":"24","author":"T Zioni","year":"2011","unstructured":"Zioni T, Buskila D, Aricha-Tamir B, Wiznitzer A, Sheiner E (2011) Pregnancy outcome in patients with fibromyalgia syndrome. J Matern Fetal Neonatal Med 24:1325\u20131328","journal-title":"J Matern Fetal Neonatal Med"},{"key":"933_CR65","doi-asserted-by":"publisher","first-page":"e0144474","DOI":"10.1371\/journal.pone.0144474","volume":"10","author":"H Zoega","year":"2015","unstructured":"Zoega H, Kieler H, N\u00f8rgaard M, Furu K, Valdimarsdottir U, Brandt L, Haglund B (2015) Use of SSRI and SNRI antidepressants during pregnancy: a population-based study from Denmark, Iceland, Norway and Sweden. PLoS One 10:e0144474","journal-title":"PLoS One"}],"container-title":["Archives of Women's Mental Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-018-0933-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00737-018-0933-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-018-0933-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T16:58:44Z","timestamp":1694537924000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00737-018-0933-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,3]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["933"],"URL":"https:\/\/doi.org\/10.1007\/s00737-018-0933-z","relation":{},"ISSN":["1434-1816","1435-1102"],"issn-type":[{"value":"1434-1816","type":"print"},{"value":"1435-1102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,3]]},"assertion":[{"value":"8 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}